101 related articles for article (PubMed ID: 14531911)
1. DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome.
Ueda M; Ota J; Yamashita Y; Choi YL; Ohki R; Wada T; Koinuma K; Kano Y; Ozawa K; Mano H
Br J Haematol; 2003 Oct; 123(2):288-96. PubMed ID: 14531911
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.
Ohmine K; Ota J; Ueda M; Ueno S; Yoshida K; Yamashita Y; Kirito K; Imagawa S; Nakamura Y; Saito K; Akutsu M; Mitani K; Kano Y; Komatsu N; Ozawa K; Mano H
Oncogene; 2001 Dec; 20(57):8249-57. PubMed ID: 11781839
[TBL] [Abstract][Full Text] [Related]
3. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation.
Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC
Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795
[TBL] [Abstract][Full Text] [Related]
4. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction.
Miyazato A; Ueno S; Ohmine K; Ueda M; Yoshida K; Yamashita Y; Kaneko T; Mori M; Kirito K; Toshima M; Nakamura Y; Saito K; Kano Y; Furusawa S; Ozawa K; Mano H
Blood; 2001 Jul; 98(2):422-7. PubMed ID: 11435312
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
[TBL] [Abstract][Full Text] [Related]
6. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes.
Mitani K; Hangaishi A; Imamura N; Miyagawa K; Ogawa S; Kanda Y; Yazaki Y; Hirai H
Leukemia; 1997 Jun; 11(6):863-5. PubMed ID: 9177441
[TBL] [Abstract][Full Text] [Related]
7. [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].
Qian J; Chen ZX; Wang W; Cen JN; Xue YQ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1260-4. PubMed ID: 15387962
[TBL] [Abstract][Full Text] [Related]
8. DNA micro-array analysis of myelodysplastic syndrome.
Mano H
Leuk Lymphoma; 2006 Jan; 47(1):9-14. PubMed ID: 16321821
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia.
Benites BD; Traina F; Duarte Ada S; Lorand-Metze IG; Costa FF; Saad ST
Eur J Haematol; 2010 Jun; 84(6):525-30. PubMed ID: 20345447
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss in the progression of myelodysplastic syndrome.
Mori N; Morosetti R; Hoflehner E; Lübbert M; Mizoguchi H; Koeffler HP
Cancer Res; 2000 Jun; 60(11):3039-42. PubMed ID: 10850454
[TBL] [Abstract][Full Text] [Related]
11. Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome.
Badran A; Yoshida A; Wano Y; Mutoh M; Imamura S; Yamashita T; Tsutani H; Inuzuka M; Ueda T
Int J Oncol; 2003 Jan; 22(1):59-64. PubMed ID: 12469185
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H
Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
[TBL] [Abstract][Full Text] [Related]
13. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
Stewart B; Verdugo M; Guthrie KA; Appelbaum F; Deeg HJ
Br J Haematol; 2003 Dec; 123(5):879-85. PubMed ID: 14632779
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
[TBL] [Abstract][Full Text] [Related]
15. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
16. Accelerated cellular senescence in myelodysplastic syndrome.
Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
[TBL] [Abstract][Full Text] [Related]
17. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
Qian J; Chen Z; Wang W; Cen J; Xue Y
Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome.
Vasikova A; Budinska E; Belickova M; Cermak J; Bruchova H
Neoplasma; 2009; 56(4):335-42. PubMed ID: 19469654
[TBL] [Abstract][Full Text] [Related]
20. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]